Although artificial intelligence in health has shown great promise, pressure is mounting for regulators around the world to act, as AI tools demonstrate potentially harmful outcomes.
By
Free series features world experts on the mindset, skillset and ways of operating to thrive during and after a crisis .
Vaccines are an especially risky proposition for pharmaceutical manufacturers since the costs are higher than for other types of drugs and demand could drop drastically once a crisis is over.
By
Wharton’s Ethan Mollick and MIT Sloan’s Bill Aulet discuss the ways generative artificial intelligence is remaking the competitive landscape of entrepreneurship.
Cell and gene therapies represent an exciting and complex new treatment type, with the potential to treat a vast range of indications.
HSI Professor Joseph Doyle is interviewed on Freakomomics, M.D. podcast
By
Since its inception, the program has helped launch 70 thriving companies
Members of the Student Sloan Healthcare Club are always responsible for this conference, but this year, the 19th, presented new complications since the event was held entirely online.
By
Hackathon is open to the public and will take place November 6-8, 2020
By
A robotic bartender, customized skincare, smart clothing, and more.
